TY - JOUR
T1 - Longitudinal analysis of the insulin-like growth factor system in African-American and European American children and adolescents
AU - Casazza, Krista
AU - Higgins, Paul B.
AU - Fernández, José R.
AU - Goran, Michael I.
AU - Gower, Barbara A.
PY - 2008/12
Y1 - 2008/12
N2 - Context: IGF-I and its binding proteins influence growth, development, and disease risk. Studies have revealed ethnic variations in the IGF system. Objective: This longitudinal studywasundertaken to test the hypothesis that the ethnic differences in the IGF system exist throughout the pubertal transition, and these differences are mediated at least in part by inherent differences in insulin dynamics. Design: This was a longitudinal study. Annual evaluations were conducted for pubertal maturation, body composition, acute insulin response to glucose (AIRg), and reproductive-endocrine profile. Hormones and binding proteins were determined using standard assays, the AIRg during a frequently sampled iv glucose tolerance test, and body composition by dual-energy x-ray absorptiometry. Mixed model analyses were used to identify and characterize ethnic differences in the IGF system across the pubertal transition after adjusting for ethnicity, sex, age, maturation status, body composition, and reproductive hormones, and to identify the contribution of insulin to IGF binding protein (IGFBP)-1. Participants: Subjects included African-American (AA) and European American children (n = 162 at baseline) aged 7-16 yr, evaluated across the pubertal transition. Main Outcome Measures: Annual data on IGF-I, IGFBP-1, and IGFBP-3 were examined. Results: IGF-I was higher in AA children at pubertal stage 1 only (P < 0.001). However, IGFBP-3 and IGFBP-1 concentrations were lower in AAs through much of puberty (P < 0.05). The lower IGFBP-1 of AAs was in part explained by greater AIRg. Conclusions: Our data suggest that the higher IGF-I and lower IGFBP-1 and IGFBP-3 levels in AAs as compared with European Americans during puberty suggest potential ethnic differences in circulating bioavailable IGF-I. In addition, higher AIRg in AAsmaylead to greater bioavailable IGF-I. Whether these differences in the IGF system account for disparities in disease risk warrants further investigation.
AB - Context: IGF-I and its binding proteins influence growth, development, and disease risk. Studies have revealed ethnic variations in the IGF system. Objective: This longitudinal studywasundertaken to test the hypothesis that the ethnic differences in the IGF system exist throughout the pubertal transition, and these differences are mediated at least in part by inherent differences in insulin dynamics. Design: This was a longitudinal study. Annual evaluations were conducted for pubertal maturation, body composition, acute insulin response to glucose (AIRg), and reproductive-endocrine profile. Hormones and binding proteins were determined using standard assays, the AIRg during a frequently sampled iv glucose tolerance test, and body composition by dual-energy x-ray absorptiometry. Mixed model analyses were used to identify and characterize ethnic differences in the IGF system across the pubertal transition after adjusting for ethnicity, sex, age, maturation status, body composition, and reproductive hormones, and to identify the contribution of insulin to IGF binding protein (IGFBP)-1. Participants: Subjects included African-American (AA) and European American children (n = 162 at baseline) aged 7-16 yr, evaluated across the pubertal transition. Main Outcome Measures: Annual data on IGF-I, IGFBP-1, and IGFBP-3 were examined. Results: IGF-I was higher in AA children at pubertal stage 1 only (P < 0.001). However, IGFBP-3 and IGFBP-1 concentrations were lower in AAs through much of puberty (P < 0.05). The lower IGFBP-1 of AAs was in part explained by greater AIRg. Conclusions: Our data suggest that the higher IGF-I and lower IGFBP-1 and IGFBP-3 levels in AAs as compared with European Americans during puberty suggest potential ethnic differences in circulating bioavailable IGF-I. In addition, higher AIRg in AAsmaylead to greater bioavailable IGF-I. Whether these differences in the IGF system account for disparities in disease risk warrants further investigation.
UR - http://www.scopus.com/inward/record.url?scp=57349117681&partnerID=8YFLogxK
U2 - 10.1210/jc.2008-0999
DO - 10.1210/jc.2008-0999
M3 - Article
C2 - 18782874
AN - SCOPUS:57349117681
SN - 0021-972X
VL - 93
SP - 4917
EP - 4923
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 12
ER -